Stay updated on Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Sign up to get notified when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.

Latest updates to the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page
- Check5 days agoChange DetectedThe page shows a revision update from v3.5.4 to v3.5.5, indicating a minor software revision. This change does not alter the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page's revision label changed from v3.5.3 to v3.5.4, signaling a new build of the study details template.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now displays Revision: v3.5.3, updating the version tag from v3.5.2. This indicates the current revision of the page has been refreshed.SummaryDifference0.1%

- Check48 days agoChange DetectedNew links/resources related to **Idiopathic Pulmonary Fibrosis**, including a **Genetic and Rare Diseases Information Center** reference, were added to the study page.SummaryDifference0.2%

- Check55 days agoChange DetectedAdded site revision label v3.5.2 and removed v3.5.0. This update does not modify trial content or user-facing information.SummaryDifference0.1%

- Check77 days agoChange DetectedRemoved the 'Interstitial lung disease 2' term and the 'Genetic and Rare Diseases Information Center' entry under Resources.SummaryDifference0.2%

Stay in the know with updates to Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.